腫瘍焼灼術の世界市場レポート 2025年

腫瘍焼灼術市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.8％で25億4,000万米ドルに成長します。予測期間の成長は、がん罹患率の増加、低侵襲手術の増加、アプリケーションの拡大、ヘルスケア費用対効果の増加、意識と教育の高まりに起因しています。予測期間の主な動向には、技術の進歩、先進的アブレーション技術の継続的開発、人工知能の統合、外来患者設定への注力、患者中心のアプローチなどが含まれます。

腫瘍焼灼術市場は、低侵襲手技の採用が増加していることから成長する見込みです。低侵襲手術は、従来の手術に比べて回復時間の短縮、合併症リスクの低減、術後の痛みの軽減などの利点があるため、小さな切開、または切開を全く必要としない医学的または外科的介入を含みます。高周波、マイクロ波、または冷凍アブレーションを含む腫瘍焼灼術技術は、周囲の健康な組織へのダメージを最小限に抑えながら、がん組織を破壊するためにこれらの処置に採用され、回復時間の短縮にさらに貢献しています。例えば、Intuitive Surgical Inc.は、2023年第4四半期に低侵襲アプローチを促進するda Vinci手術システムの導入件数が2022年比で12%増加したと報告しており、低侵襲手術の勢い、ひいては腫瘍焼灼術市場の成長を裏付けています。

腫瘍焼灼術市場の主要企業は、治療効果を高め、治療可能な腫瘍の範囲を広げるための技術革新に注力しています。技術革新の1つの分野は、骨腫瘍焼灼術システムなどの特殊製品の開発です。これらのシステムは、骨腫瘍を治療するための低侵襲手技専用に設計されています。最近、Medtronic plc社は、2024年3月にOsteoCool 2.0骨腫瘍焼灼術システムのFDA 510（k）認可を取得しました。このアップグレードされたシステムは、痛みを伴う骨転移や骨様骨腫などの良性骨腫瘍の治療用に調整されています。内部冷却された4本のプローブを同時に使用できるため、治療の柔軟性が向上します。このシステムは、Stryker OptaBlateTM骨腫瘍焼灼術システムなどの同等のシステムを大幅に上回る、強化された出力を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腫瘍焼灼術 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腫瘍焼灼術市場：成長率分析
• 世界の腫瘍焼灼術市場の実績：規模と成長, 2019-2024
• 世界の腫瘍焼灼術市場の予測：規模と成長, 2024-2029, 2034F
• 世界腫瘍焼灼術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腫瘍焼灼術市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 熱アブレーション
• 化学アブレーション
• 世界の腫瘍焼灼術市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮的
• 腹腔鏡
• 外科手術
• 世界の腫瘍焼灼術市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腎臓がん
• 肝臓がん
• 乳がん
• 肺がん
• 前立腺がん
• その他のがん
• 世界の腫瘍焼灼術市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 腫瘍学センター
• その他のエンドユーザー
• 世界の腫瘍焼灼術市場熱アブレーションのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高周波アブレーション（RFA）
• マイクロ波アブレーション（MWA）
• 凍結療法
• レーザーアブレーション
• 高強度焦点式超音波（HIFU）
• 世界の腫瘍焼灼術市場化学アブレーションのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• エタノールアブレーション
• 酢酸アブレーション
• 化学療法に基づくアブレーション（化学塞栓術）

第7章 地域別・国別分析

• 世界の腫瘍焼灼術市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腫瘍焼灼術市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腫瘍焼灼術市場：競合情勢
• 腫瘍焼灼術市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Olympus Corporation
• Terumo Corporation
• Varian Medical Systems Inc.
• Merit Medical Systems Inc.
• Bioventus LLC
• Accuray Incorporated
• AtriCure Inc.
• AngioDynamics Inc.
• EDAP TMS S.A.
• NeuWave Medical Inc.
• Mirabilis Medical Inc.
• STARMed Co. Ltd.
• Profound Medical Corp.
• RF Medical Co. Ltd.
• IceCure Medical Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腫瘍焼灼術市場2029：新たな機会を提供する国
• 腫瘍焼灼術市場2029：新たな機会を提供するセグメント
• 腫瘍焼灼術市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tumor ablation is a minimally invasive medical procedure designed to eliminate cancerous tissues by applying extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This approach is commonly used for treating small tumors or those located in challenging anatomical locations.

The primary types of tumor ablation include thermal ablation and chemical ablation. Thermal ablation involves using extreme heat to destroy abnormal or diseased tissue, and it is employed across various treatments such as percutaneous, laparoscopic, and surgical procedures for conditions such as kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, among others. End users of these techniques include hospitals, oncology centers, and other healthcare facilities.

The tumor ablation market research report is one of a series of new reports from The Business Research Company that provides tumor ablation market statistics, including the tumor ablation industry's global market size, regional shares, competitors with a tumor ablation market share, detailed tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation industry. This tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tumor ablation market size has grown rapidly in recent years. It will grow from $1.45 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to the development of more precise and efficient ablation techniques, rising healthcare expenditure across emerging economies, the demographic shift towards older populations, the increasing burden of cancer, and the rising prevalence of cancer globally.

The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing cancer incidence, growing minimally invasive procedures, expanding applications, increasing healthcare cost-effectiveness, and growing awareness and education. Major trends in the forecast period include technological advancements, Continued development of advanced ablation technologies, integration of artificial intelligence, focus on outpatient settings, and patient-centric approaches.

The tumor ablation market is poised for growth due to the increasing adoption of minimally invasive procedures. Minimally invasive procedures involve medical or surgical interventions that require small incisions or no incisions at all, driven by their benefits such as reduced recovery times, lower complication risks, and less post-operative pain compared to traditional surgeries. Tumor ablation techniques, including radiofrequency, microwave, or cryoablation, are employed in these procedures to destroy cancerous tissues while minimizing damage to surrounding healthy tissue, further contributing to quicker recovery times. For example, Intuitive Surgical Inc. reported a 12% increase in placements of da Vinci surgical systems, which facilitate minimally invasive approaches, in the fourth quarter of 2023 compared to 2022, underscoring the momentum behind minimally invasive procedures and, consequently, the tumor ablation market's growth.

Leading companies in the tumor ablation market are focusing on innovation to enhance treatment effectiveness and broaden the scope of treatable tumors. One area of innovation is the development of specialized products such as bone tumor ablation systems. These systems are designed specifically for minimally invasive procedures to treat bone tumors. Recently, Medtronic plc received FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system in March 2024. This upgraded system is tailored for treating painful bone metastases and benign bone tumors such as osteoid osteoma. It allows for the simultaneous use of four internally cooled probes, offering greater flexibility in treatment. The system delivers enhanced power, significantly exceeding that of comparable systems such as the Stryker OptaBlateTM bone tumor ablation system.

In December 2022, Boston Scientific Corporation, a US-based biomedical manufacturing company, acquired Acotec Scientific Holdings Ltd. for $523 million. Through this acquisition, Boston Scientific aims to enhance its presence in China and globally commercialize the product portfolio of Acotec Scientific. Acotec Scientific Holdings Ltd., a China-based medical technology company, specializes in radiofrequency ablation technologies, drug-coated balloons, and thrombus aspiration catheters.

Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.

North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor ablation market includes revenues earned by entities by providing services such as consultation, diagnosis, chemical ablation, and post-procedure care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor ablation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Thermal Ablation; Chemical Ablation
• 2) By Types Of Treatment: Percutaneous; Laparoscopic; Surgical
• 3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Cancer
• 4) By End Users: Hospitals; Oncology Centers; Other End Users
• Subsegments:
• 1) By Thermal Ablation: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)
• 2) By Chemical Ablation: Ethanol Ablation; Acetic Acid Ablation; Chemotherapy-Based Ablation (Chemoembolization)
• Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Ablation Market Characteristics

3. Tumor Ablation Market Trends And Strategies

4. Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Tumor Ablation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tumor Ablation Market Growth Rate Analysis
• 5.4. Global Tumor Ablation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tumor Ablation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tumor Ablation Total Addressable Market (TAM)

6. Tumor Ablation Market Segmentation

• 6.1. Global Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thermal Ablation
• Chemical Ablation
• 6.2. Global Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Percutaneous
• Laparoscopic
• Surgical
• 6.3. Global Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kidney Cancer
• Liver Cancer
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Other Cancer
• 6.4. Global Tumor Ablation Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Oncology Centers
• Other End Users
• 6.5. Global Tumor Ablation Market, Sub-Segmentation Of Thermal Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiofrequency Ablation (RFA)
• Microwave Ablation (MWA)
• Cryoablation
• Laser Ablation
• High-Intensity Focused Ultrasound (HIFU)
• 6.6. Global Tumor Ablation Market, Sub-Segmentation Of Chemical Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ethanol Ablation
• Acetic Acid Ablation
• Chemotherapy-Based Ablation (Chemoembolization)

7. Tumor Ablation Market Regional And Country Analysis

• 7.1. Global Tumor Ablation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tumor Ablation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Ablation Market

• 8.1. Asia-Pacific Tumor Ablation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Ablation Market

• 9.1. China Tumor Ablation Market Overview
• 9.2. China Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Ablation Market

• 10.1. India Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Ablation Market

• 11.1. Japan Tumor Ablation Market Overview
• 11.2. Japan Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Ablation Market

• 12.1. Australia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Ablation Market

• 13.1. Indonesia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Ablation Market

• 14.1. South Korea Tumor Ablation Market Overview
• 14.2. South Korea Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Ablation Market

• 15.1. Western Europe Tumor Ablation Market Overview
• 15.2. Western Europe Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Ablation Market

• 16.1. UK Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Ablation Market

• 17.1. Germany Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Ablation Market

• 18.1. France Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Ablation Market

• 19.1. Italy Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Ablation Market

• 20.1. Spain Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Ablation Market

• 21.1. Eastern Europe Tumor Ablation Market Overview
• 21.2. Eastern Europe Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Ablation Market

• 22.1. Russia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Ablation Market

• 23.1. North America Tumor Ablation Market Overview
• 23.2. North America Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Ablation Market

• 24.1. USA Tumor Ablation Market Overview
• 24.2. USA Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Ablation Market

• 25.1. Canada Tumor Ablation Market Overview
• 25.2. Canada Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Ablation Market

• 26.1. South America Tumor Ablation Market Overview
• 26.2. South America Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Ablation Market

• 27.1. Brazil Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Ablation Market

• 28.1. Middle East Tumor Ablation Market Overview
• 28.2. Middle East Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Ablation Market

• 29.1. Africa Tumor Ablation Market Overview
• 29.2. Africa Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Ablation Market Competitive Landscape And Company Profiles

• 30.1. Tumor Ablation Market Competitive Landscape
• 30.2. Tumor Ablation Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Ablation Market Other Major And Innovative Companies

• 31.1. Olympus Corporation
• 31.2. Terumo Corporation
• 31.3. Varian Medical Systems Inc.
• 31.4. Merit Medical Systems Inc.
• 31.5. Bioventus LLC
• 31.6. Accuray Incorporated
• 31.7. AtriCure Inc.
• 31.8. AngioDynamics Inc.
• 31.9. EDAP TMS S.A.
• 31.10. NeuWave Medical Inc.
• 31.11. Mirabilis Medical Inc.
• 31.12. STARMed Co. Ltd.
• 31.13. Profound Medical Corp.
• 31.14. RF Medical Co. Ltd.
• 31.15. IceCure Medical Ltd.

32. Global Tumor Ablation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Ablation Market

34. Recent Developments In The Tumor Ablation Market

35. Tumor Ablation Market High Potential Countries, Segments and Strategies

• 35.1 Tumor Ablation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tumor Ablation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tumor Ablation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer